Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Piperidinecarboxylic acid, 1-pyrazinyl (9CI), is a heterocyclic organic compound characterized by the molecular formula C11H16N2O2. It features a piperidine ring and a pyrazine ring, which contribute to its unique structure and properties. 4-Piperidinecarboxylicacid,1-pyrazinyl-(9CI) serves as a valuable building block in the pharmaceutical industry, playing a crucial role in the synthesis of various drug molecules.

606104-21-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 606104-21-6 Structure
  • Basic information

    1. Product Name: 4-Piperidinecarboxylicacid,1-pyrazinyl-(9CI)
    2. Synonyms: 4-Piperidinecarboxylicacid,1-pyrazinyl-(9CI);1-PYRAZINYL-4-PIPERIDINECARBOXYLIC ACID;1-(2-Pyrazinyl)-4-piperidinecarboxylic acid;1-(2-pyrazinyl)-4-Piperidine carbocylic acid
    3. CAS NO:606104-21-6
    4. Molecular Formula: C10 H13 N3 O2
    5. Molecular Weight: 207.23
    6. EINECS: N/A
    7. Product Categories: PIPERIDINE;PYRAZINE
    8. Mol File: 606104-21-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.291
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-Piperidinecarboxylicacid,1-pyrazinyl-(9CI)(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-Piperidinecarboxylicacid,1-pyrazinyl-(9CI)(606104-21-6)
    11. EPA Substance Registry System: 4-Piperidinecarboxylicacid,1-pyrazinyl-(9CI)(606104-21-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 606104-21-6(Hazardous Substances Data)

606104-21-6 Usage

Uses

Used in Pharmaceutical Industry:
4-Piperidinecarboxylic acid, 1-pyrazinyl-(9CI) is used as a key intermediate in the synthesis of drug molecules for a range of therapeutic indications. Its unique structure and properties make it an essential component in drug discovery and development efforts.
4-Piperidinecarboxylicacid,1-pyrazinyl-(9CI)'s potential applications in the development of new medications include:
1. As a building block for the synthesis of various drug molecules, contributing to the creation of innovative therapeutic agents.
2. Facilitating the exploration of new chemical entities with potential therapeutic benefits.
3. Enhancing the understanding of the compound's effects on biological systems, which can inform the design of more effective and targeted medications.

Check Digit Verification of cas no

The CAS Registry Mumber 606104-21-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,6,1,0 and 4 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 606104-21:
(8*6)+(7*0)+(6*6)+(5*1)+(4*0)+(3*4)+(2*2)+(1*1)=106
106 % 10 = 6
So 606104-21-6 is a valid CAS Registry Number.

606104-21-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-pyrazin-2-ylpiperidine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1-Pyrazin-2-yl-piperidine-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:606104-21-6 SDS

606104-21-6Upstream product

606104-21-6Downstream Products

606104-21-6Relevant articles and documents

1, 4-DISUBSTITUTED PIPERIDINES AS VASOPRESSIN RECEPTOR VIA ANTAGONISTS

-

Page/Page column 44; 46, (2010/09/17)

The present invention provides compounds of formula (1) compositions comprising such compounds; the use of such compounds in therapy (such as in the treatment of dysmenorrhoea); and methods of treating patients with such compounds; wherein A and G are as defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 606104-21-6